Average Co-Inventor Count = 4.16
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (43 from 3,681 patents)
2. E. R. Squibb Sons, Inc. (6 from 1,624 patents)
3. Other (1 from 832,680 patents)
4. University of Pennsylvania (2,595 patents)
50 patents:
1. 12473304 - Heterocyclic PAD4 inhibitors
2. 11053197 - Carbazole derivatives
3. 10865191 - Heterocyclic compounds useful as modulators of TNF alpha
4. 10676434 - Carbazole derivatives
5. 10435415 - Substituted tetrahydrocarbazole and carbazole carboxamide compounds
6. 10266491 - Carbazole derivatives
7. 10214537 - Bicyclic heteroaryl amine compounds
8. 10106559 - Substituted tetrahydrocarbazole and carbazole carboxamide compounds
9. 10023576 - Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors
10. 9334290 - Substituted tetrahydrocarbazole and carbazole carboxamide compounds
11. 8614332 - Substituted pyrazolylamides useful as glucokinase activators
12. 8557841 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
13. 8232291 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
14. 8153677 - Substituted pyrazolylamide compounds useful as glucokinase activators
15. 7977353 - Heterocyclic aromatic compounds useful as growth hormone secretagogues